Table 3

Prevalence (or CI 95%) of TB in patients with ERA (ESPOIR) and ESpA (DESIR) compared with the French general population in 2008

GenderAge groupsFrench general populationESPOIR
Patients with ERA
DESIR
Patients with ESpA
NPrevalence (%)NCI 95% (%)NCI 95% (%)
Men20–3912760.0200 to 12.9820.15 to 3.44
40–444300.0200 to 26.7600 to 17.81
45–494270.0210.04 to 37.9110.16 to 17.51
50–544270.0200 to 12.64
55–594700.0321.29 to 25.76
60–644290.0321.46 to 28.47
65–693070.0300 to 25.35
Women20–3911610.0210.02 to 2.7710.02 to 2.70
40–443140.0210.09 to 9.9810.11 to 12.47
45–493190.0231.04 to 12.0310.13 to 15.07
50–543530.0230.92 to 10.69
55–593480.0295.2 to 19.41
60–642860.0253.16 to 19.41
65–692630.0256.53 to 36.48
Total68100.02324.69 (3.28 to 6.63)60.99 (0.4 to 2.25)
  • N, number with a diagnosis of tuberculosis in each gender and age group.

  • DESIR, Devenir des Spondylarthropathies Indifférenciées Récentes; ERA, early rheumatoid arthritis; ESpA, early axial spondyloarthritis; ESPOIR, Etude et Suivi des Polyarthrites Indifférenciées Récentes; TB, tuberculosis.